top of page
Search


Apotek Signal: Quantifying Clinical Trial Success Where Asset Value Is Decided
Retrospective Probability of Success (PoS) answers “what usually happens across programs.” Apotek Signal answers “what is likely to happen for this asset.” Key Takeaways Apotek Signal quantifies clinical risk at the asset level : It estimates the probability that a specific trio of drug–target–indication will succeed at a given clinical phase. Phase-aware by design : Separate models for clinical trial phase I, II, and III reflect how decision criteria change across developme
Esther Chen
Dec 21, 20254 min read


The Evolution of Measuring Marketing Effectiveness
Marketing measurement has gone through three distinct phases:
1. Legacy MMM Era (pre-2010s)
2. Attribution Boom (2010s)
3. MMM Rebirth (2020s)
This isn’t a story about preference. It’s a story about adaptation to thrive in the everchanging business world.
Caslow Chien
Dec 12, 20255 min read


Apotek Genesis "Lead Optimization": Preemptive Drug Asset Evaluation
How optimizing leads early can foresee risks, ensure safety and developability, and protect intellectual properties

Yu-Feng Wei
Dec 12, 20253 min read


Why Detail Matters for Causal Analytics? Prepping Your Data to Drive Impactful Decisions
Data Detail is Crucial: To perform causal analytics like Marketing Mix Modeling, you must preserve raw, event-level data (joint distributions). Summary reports (marginals) discard the necessary context to attribute success to specific combinations of customer traits.
Avoid the "Average" Trap: Aggregated data can hide the true story. Two completely different customer behaviors can look identical in summary reports, making accurate attribution impossible without the raw source
Steven Ho
Dec 9, 20255 min read
bottom of page